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Abstract Despite successful mass drug administration and
vector control programs, the nematode Onchocerca volvu-
lus is far from being eradicated. Therefore, new long-term
sterilizing or macrofilaricidal drugs are needed. The
depletion of Wolbachia endobacteria using doxycycline
leads to long-term sterilizing effects and macrofilaricidal
activity against female filariae of more than 60%. The
worms die or degenerate 18–27 months after doxycycline.
However, during this time patients may be exposed to new
infections. We evaluated these newly acquired worms in
onchocercomas of doxycycline-treated patients in relation
to transmission using morphology, histochemistry, and
immunohistology. On an average, 10% of the female
filariae had been newly acquired per year in the treated
groups. Our observations showed: (a) Sixty-three of 68
newly acquired worms harbored many intact Wolbachia,
whereas none of the other surviving worms contained many
bacteria. (b) Higher percentages of dead filariae than
originally reported were calculated, when the new worms
were excluded, indicating a stronger macrofilaricidal
activity than previously reported. The difference was
significant for female filariae after doxycycline treatment
for 6 weeks. (c) Only newly acquired worms presented
normal embryogenesis and microfilariae production after
sufficient treatment. We conclude that newly acquired
filariae have to be considered when evaluating drug
efficacy in onchocerciasis.
Abbreviations
APR O. volvulus aspartic protease
IVM ivermectin
L3 infective larvae
mf microfilaria (e)
WSP Wolbachia surface protein
Introduction
Onchocerciasis can lead to devastating skin disease and
blindness. Ivermectin (IVM, Mectizan®) distribution within
the African Programme for Onchocerciasis Control (APOC)
had a marked impact on the disease, reducing prevalence of
blindness and transmission of onchocerciasis. Recent
surveys done by APOC indicate that approximately
37 million people may still be infected (Basañez et al.
2006), and modeling studies suggest that IVM treatments
alone may not lead to onchocerciasis elimination (Alley et
al. 2001). This and the risk of emergence of IVM-resistant
parasites necessitate the search for alternative drugs or drug
combinations, preferably with macrofilaricidal or long-
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Clinical trials require optimal methods for the evaluation
of drug activity, since for ethical and economical reasons
reliable information should be gained from as few patients
with as little risk as possible. Usually, onchocerciasis trials
are carried out in endemic areas with still ongoing
transmission. This implies that patients are exposed and
new infections will be acquired. To evaluate the efficacy of
a drug or vaccine, it is necessary to differentiate between
worms present at the time of drug or vaccine administration
and worms acquired during long observation periods. Such
long periods are needed for the detection of long-term
sterilizing or slow macrofilaricidal effects.
An example for such long observation periods is the
treatment with antibiotics. Onchocerca volvulus and other
filariae contain Wolbachia bacteria, which are essential
endosymbionts for parasite fertility and survival. Several
clinical trials with doxycycline have already been completed.
The first study demonstrated that a six-week treatment with
100 mg doxycycline per day leads to the elimination of intact
Wolbachia after 6–12 months and to long-term sterilization
(Hoerauf et al. 2003). After a longer observation of 20–
27 months, up to 60% of the female filariae were found dead
in two recent studies (Hoerauf et al. 2008, 2009). Since these
studies were performed in an area with ongoing transmission,
a proportion of the worms that were still living after these
longer observation periods must have been newly acquired.
Consequently, their subtraction from the number of all
observed worms will change the figures previously reported
for the efficacy of doxycycline. We have described the
morphological and immunohistological criteria for the
diagnosis of newly acquired worms in a previous report
(Specht et al. 2009). Here, we assess the number of newly
acquired young worms in doxycycline trials using these
criteria. Our hypotheses for this study were: (a) Twelve or
more months after doxycycline all O. volvulus filariae with
many not degenerated Wolbachia were worms newly
acquired after treatment. (b) The exclusion of the worms
newly acquired after doxycycline leads to lower percen-
tages of living worms and hence to higher percentages of
dead filariae indicating a stronger macrofilaricidal efficacy.
(c) Eighteen or more months after doxycycline all worms
with normal embryogenesis and microfilariae (mf) produc-
tion have been acquired after the treatment.
Patients, material, and methods
Study area
The results presented here are mainly based on two
doxycycline trials performed between 2003 and 2006
(Hoerauf et al. 2008, 2009). In addition, data were also
considered from the first trial (Hoerauf et al. 2003) and
from further dose-finding trials in 2000–2002 (unpublished
data). Patients for these studies had been selected in several
villages in the Central Region of Ghana. In 1999, this area
was found to be hyperendemic for onchocerciasis during
rapid assessment of 30 men older than 19 years per
village in Upper Denkyira and Assin districts, with mf
carrier rates between 47% and 90% of the examined men
(R. Horstmann and D.W. Büttner). In most of the
villages, IVM treatment had been administered beginning
in 1999, but a reduction of the infectivity rates and the
loads of infective larvae (L3) in Simulium sanctipauli
was not observed in the trial villages between 2002 and
2006 (Kutin et al. 2004;R .G a r m s ,B e r n h a r dN o c h t
Institute, unpublished report, 2006). Transmission was
ongoing during the trials.
Treatment of patients
Patients were treated with 100 or 200 mg doxycycline per
day for 4, 5, or 6 weeks. Most patients took a single dose of
IVM a few months after doxycycline. Control patients
received matching placebos or remained untreated, except
for IVM. Onchocercomas were extirpated aseptically under
local anesthesia in the regional hospital in Dunkwa. Patients
were nodulectomized at various follow-up time points after
the start of treatment, ranging from 2–39 months (Hoerauf
et al. 2003, 2008, 2009).
Immunohistology
Onchocercomas were fixed in 70–80% ethanol or 4%
phosphate-buffered formaldehyde solution and embedded
in paraffin using standard methods. Hematoxylin eosin
(Merck, Darmstadt, Germany) was used for all nodules. For
the detection of iron in the filarial tissues, Gomori’s iron
method was applied for all nodules selected for this study,
using acid potassium ferrocyanide solution and nuclear fast
red as counter stain (Luna 1968). For immunohistology, the
alkaline phosphatase antialkaline phosphatase technique
was applied according to the recommendations given by
the manufacturer (DakoCytomation, Hamburg, Germany).
An antiserum raised against lysosomal aspartic protease
(APR) in a rabbit (Jolodar et al. 2004,s u p p l i e db yP DD r
Norbert Brattig, Bernhard Nocht Institute) was used as
primary antibody to assess vitality and to estimate worm
age, diluted 1:1,000–1:4,000. To demonstrate the pres-
ence of Wolbachia, a rabbit antiserum against Dirofilaria
immitis Wolbachia surface protein (WSP, Bazzocchi et al.
2000, supplied by Prof. Claudio Bandi, Milano, Italy) was
used, diluted 1:200–1:4,000. As secondary antibody,
mouse antirabbit immunoglobulin (clone MR12/53, Dako-
24 Parasitol Res (2009) 106:23–31Cytomation) was applied. Fast Red TR salt (Sigma,
Deisenhofen, Germany) was used as chromogen and
hematoxylin (Merck) served as the counter stain. For the
electron microscopic (Fig. 1 (6)) showing degenerated
Wolbachia, standard methods were used as described
previously (Pfarr et al. 2008).
Onchocercomas were analyzed for morphological and
immunohistological characteristics of newly acquired
young worms. All filariae were examined for vitality,
productivity, presence of Wolbachia, and the human nodule
tissue was screened for mf. Morphological criteria for the
estimation of the worm age and vitality have been described
(Büttner et al. 1988; Franz 1988; Schulz-Key 1988; Duke
1991 and in detail by Specht et al. 2009). The classification
of female O. volvulus follows Duke et al. (2002) with minor
modifications. Two authors (DWB and SS) examined the
sections independently. When the examiners did not agree,
slides were reexamined, which mostly led to a consensus.
In doubtful cases, the worms were not counted as newly
acquired.
Statistics
The paired t test was applied to test differences between
previously observed and newly calculated rates of dead
filariae, using GraphPad® Prism Software.
Results
Number of newly acquired filariae
Here, we report the results of our reexamination of the
onchocercomas from two recent doxycycline trials
(Hoerauf et al. 2008, 2009) using the criteria for the
differentiation between young and old O. volvulus pub-
lished previously (Specht et al. 2009). Tables 1 and 2
present the numbers and percentages of living young
worms identified as newly acquired in different patient
groups: a total of 68 female and 32 male filariae. The
number of newly acquired males (Table 2) was probably
slightly underestimated, because in nodule sections with
only few male worm sections not all distinct criteria for
the age estimation could be applied and some male
worms near to the edge of the nodule may have been
completely missed. In the treatment groups, on average
10% (median 9.0%) of the female and 9% (median
6 . 4 % )o ft h em a l ef i l a r i a ew e r ei d e n t i f i e dp e ry e a ra s
newly acquired after doxycycline treatment. In the
untreated groups on average, only 7% females and 5%
male worms were identified as newly acquired per year,
because the diagnosis was more difficult for untreated
filariae.
Elimination of Wolbachia by doxycycline treatment
The elimination of Wolbachia by doxycycline is the
precondition for sterilization and death of the filariae.
Using immunohistology and PCR, we have shown that
most filariae lose their endobacteria during the months after
sufficient doxycycline treatment (Hoerauf et al. 2003, 2008,
2009). However, always small numbers of worms with
many morphologically intact endobacteria were observed
after 20–27 months and this raised the question whether
they had been doxycycline-treated or were acquired only
afterwards.
The number of bacteria in immature worms is limited, as
it is in L3, and therefore we only saw endobacteria in three
of seven immature worms (Fig. 1), which had been newly
acquired during the last year before nodulectomy (accord-
ing to the definition of these worms being immature). More
than 19 months after doxycycline 23 nulliparous worms
were identified as newly acquired. They were all Wolba-
chia-positive (Table 1, Figs. 1 (2) and (3)). During the
months after, doxycycline bacteria started to degenerate in
the hypodermis and then in the oocytes. Therefore, a few
worms harbored small numbers of endobacteria in degen-
erated oocytes 11 months after treatment, but these bacteria
were obviously degenerated (compare Figs. 1 (4) and (5)).
The degenerated bacteria showed an irregular cytoplasm
with electron dense inclusions (Fig. 1 (6)) compared to
living Wolbachia (e.g., Fig. 1 in Pfarr et al. 2008). Eleven
and more months after sufficient doxycycline treatment, the
Wolbachia-positive male worms showed the criteria of
young worms (Figs. 1 (7) and (8)) when compared to
adjacent old female worms. Especially the low iron content
of these young worms was striking (Fig. 1 (8)). All 17
productive female worms identified as newly acquired after
doxycycline contained many morphologically intact endo-
bacteria (Table 1, Figs. 2 (9), (10), (11) and (14)), except
one worm with few bacteria. In contrast, several young
fecund females were observed during the first 6 months of
observation (Table 1 in Hoerauf et al. 2003) and these
young as well as old females contained no Wolbachia since
they all had been acquired before treatment
Macrofilaricidal activity of doxycycline
Secondly, we hypothesized that taking new worms into
account, this would affect the macrofilaricidal activity of
doxycycline. We subtracted the numbers of newly acquired
worms from those of all observed worms and recalculated
new percentages of dead worms using the new figures of all
worms. In all groups of untreated and doxycycline-treated
patients, the corrected percentages of dead female filariae
were higher than the original figures, since these included
the newly acquired filariae (Table 2). The difference was
Parasitol Res (2009) 106:23–31 25significant for the female worms treated 6 weeks (p=
0.050). The corrected percentages were also higher for
males except for the three groups with 0%. Combining all
doxycycline-treated groups examined after 20–39 months
into one group, the difference between the previous and the
corrected percentages was significant for the female filariae
(p=0.0018, paired t test). For the male worms, the
difference showed only a trend for higher rates of dead
worms, but it was not significant (p=0.073 for all and p=
0.094 for 6 weeks). Hence, the macrofilaricidal activity of
doxycycline was higher in the previous studies than
originally reported (Hoerauf et al. 2008, 2009).
Cessation of embryogenesis and mf production
In our previous reports, we had observed that a small
number of filariae presented still normal embryogenesis and
mf were found in the human nodule issue and the skin up to
Fig. 1 1 A Wolbachia-positive (arrow) immature female O. volvulus,
excised 20 months after 100 mg doxycycline daily for 5 weeks, was
certainly newly acquired. The uterus (ut) is small and empty. WSP,
scale bar=50µm. 2, 3 A nulliparous young Wolbachia-positive
(arrows) female filaria with no iron in the gut was certainly newly
acquired in contrast to the bacteria-negative, doxycycline-treated old
female with much iron in the gut (arrowheads). Excised 11 months
after 100 mg doxycycline for 6 weeks. 2 WSP. 3 Iron stain, scale bar=
50µm. 4 Living endobacteria (arrows) in intact oocytes in the uterus
(ut) of an untreated worm. WSP, scale bar=50µm. 5 Degenerated
endobacteria (arrows) in degenerated oocytes in the uterus (ut)o fa
doxycycline-treated female worm. Excised 11 months after 100 mg
doxycycline for 6 weeks in contrast to the intact endobacteria in 4.
WSP, scale bar=50µm. 6 Electron micrograph of an oocyte with
degenerated Wolbachia (arrows), which show irregular cytoplasm and
electron dense inclusions. Excised 11 months after 100 mg doxycy-
cline for 6 weeks. Scale bar=1µm. 7 A Wolbachia-positive (arrows)
newly acquired young male worm with intact spermatogenesis (sp),
contains no iron in the gut (arrowheads). Excised 27 months after
200 mg doxycycline for 6 weeks, WSP, iron stain, scale bar=50 mm.
8 Wolbachia-positive (arrows) newly acquired young male worm with
intact spermatogenesis (sp), contains no iron in the gut (arrowheads).
Excised 27 months after 200 mg doxycycline for 6 weeks, WSP, iron
stain, scale bar=50 mm
26 Parasitol Res (2009) 106:23–3139 months after doxycycline (Hoerauf et al. 2008, 2009).
Our hypothesis was that these productive worms had not
been treated since they had been newly acquired after
doxycycline. Because of the long prepatency, newly
acquired worms need a period of one to several years to
produce mf. We observed 24 productive new females
among the newly acquired worms (Table 1; Fig. 2 (14)).
One of them was doubtful since it was seen already after
6 months. But we found no old productive worms after
sufficient doxycycline treatment for 5 or 6 weeks (see
Table 4 in Hoerauf et al. 2008 and Table 3, 2009). Twenty
to 27 months after sufficient doxycycline treatment, only in
those few nodules containing newly acquired Wolbachia-
positive productive worms numerous bacteria-positive mf
were found adjacent to these female worms (Figs. 2 (14)
and (15)). Since we did not detect Wolbachia-positive mf
later than 6 months after doxycycline in nodules without
new females, we assume that mf was only produced by new
females, and the sterilization of the female worms present at
the time of doxycycline treatment was complete.
Discussion
To fully evaluate macrofilaricidal drug efficacy in human
onchocerciasis, worms present at the time of treatment have
to be differentiated from those acquired afterwards, because
longer trial periods of a few years need to be adhered to,
during which the treated individuals are still being exposed
to L3. In the present study, we used morphological,
histochemical, and immunohistological criteria for the
diagnosis of potentially newly acquired worms from older
ones in doxycycline treated patients. Doxycycline leads to
long-term sterilization by elimination of Wolbachia endo-
symbionts (Hoerauf et al. 2003, 2008).
At 18–39 months, no endobacteria were found in worms
that met the criteria of older worms and must therefore
have already been present during treatment. We have
no evidence that there is any recovery of endobacterial
populations in worms arising from a few bacteria that we
may not have detected. But this can only be definitely
proven with a longer observation until all sufficiently
treated filariae have died. In contrast, all worms that were
described at that time point as young, including fecund
ones, contained many morphologically intact Wolbachia.
We have to admit that scanning for worms with many
bacteria during histological examination has facilitated the
detection of newly acquired worms in the doxycycline
treatment groups as the higher percentages show. However,
all of them were confirmed as young worms based on other
criteria than the endobacteria.
A slightly but significantly higher macrofilaricidal activity
than originally reported was observed after doxycycline
treatment, when newly acquired worms were considered.
Table 1 Embryogenesis and presence of Wolbachia in newly acquired O. volvulus
Treatment
group
Months after
study onset
Number of
patients/nodules
Number of living female worms
Newly acquired Number of
newly acquired
Number containing
many Wolbachia
All Immature Oocytes
only
Embryos/
mf
Placebo
a 6 13/14 29 0 1 0 1 1
20 16/51 70 1 4 6 11 10
27 7/38 61 0 3 2 5 5
Doxycycline
a, b
4 weeks
20 7/36 27 0 1 1 2 2
27 7/23 20 0 4 2 6 6
39 2/13 12 0 1 1 2 2
Doxycycline
a, b
6 weeks
6 11/19 32 0 0 1 1 0
20 13/62 42 3 5 3 11 9
27 5/27 15 1 3 1 5 5
39 2/7 9 0 2 2 4 4
Not treated
c 27 10/41 51 1 5 0 6 5
Doxycycline
c
5 weeks
20 12/49 34 1 2 2 5 4
27 13/47 49 0 5 4 9 9
aHoerauf et al. (2008)
b39 months after treatment: unpublished data
cHoerauf et al. (2009)
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dead after 18–39 months. This observation period might
therefore not be long enough for all filariae to die. We believe
that they will die later as degenerated filariae after long years
of vector control do (Albiez et al. 1987; Büttner et al. 1990).
However, we cannot formally exclude that a few of them
may recover in spite of their severe degeneration. On the
other hand, survival of a small number of worms is accepted
for other anthelmintic drugs, e.g., for schistosomes (WHO
1995).
Embryogenesis and mf production were interrupted by
doxycycline treatment. It was clearly visible that 11–
39 months after treatment, all Wolbachia-positive mf were
found adjacent to an endobacteria-harboring female with
the characteristics of a newly acquired worm and all these
mf were bacteria-positive. We assume that all the
endobacteria-positive mf seen 18 months and later had
been produced by newly acquired filariae. The life
expectancy of mf varies, but on average 18 months is
assumed (Plaisier et al. 1991). Probably, none or only few
Fig. 2 A newly acquired young female worm full of endobacteria-
positive morulae in the uterus (ut) and with sparsely iron in the gut
(arrowheads). Excised 27 months after 200 mg doxycycline daily for
6 weeks. 9 WSP, 10 iron stain, scale bar=100µm. 11 A newly
acquired young productive female worm with mature mf in the uterus
(ut) and a light gut (arrowhead) contains Wolbachia (arrows). Excised
27 months after 100 mg doxycycline for 5 weeks. WSP, scale bar=
100µm. 12 A Wolbachia-positive mf in a nodule from an untreated
patient. WSP, scale bar=10µm. 13 Two months after 100 mg
doxycycline daily for 6 weeks are still mf in the nodule but they no
longer harbor endobacteria. WSP, scale bar=10µm. 14 Adjacent to a
newly acquired, young, endobacteria-positive (ba) female worm with
a light gut (arrowhead) are many Wolbachia-positive mf (arrows).
Excised 27 months after 100 mg doxycycline for 5 weeks. WSP, scale
bar=50µm. 15 Detail of a Wolbachia-positive mf from 14. WSP, scale
bar=10µm
Parasitol Res (2009) 106:23–31 29doxycycline-treated mf survived after 20 and more months.
This is probably also true for the mf in the skin (Hoerauf et
al. 2008, 2009). The results confirm a long-term sterilizing
effect of doxycycline. Since the treated surviving females
had either degenerated oocytes or empty uteri, the sterili-
zation is probably permanent. Further, these severely
degenerated filariae will probably die and not recover.
We assume that 9–10% of the living worms observed at
the follow-up examinations had been newly acquired
annually since the transmission was ongoing in the trial
villages (Kutin et al. 2004; R. Garms, Bernhard Nocht
Institute, unpublished report, 2006). This percentage is
sufficient to replenish the number of worms dying naturally,
which may be about 10% each year, if we assume an
average life expectancy of 10 years. Plaisier et al. (1991)
report 9–11 years as average life expectancy in different
villages in the savannah areas. We estimated similar figures
based on the decline of worms in the upper part of the body
in children (Büttner and Weiss 1984) and after vector
control in Burkina Faso and Ghana (Büttner et al. 1988,
1990). In Burkina Faso, we nodulectomized patients after
interruption of transmission in 1977, 1978, 1980, 1983, and
1987 and analyzed their worm loads, which decreased
continually. After these 11 years, the burden of living
worms per person was only 10% of that in 1977 and some
of these worms had obviously been acquired in neighboring
Ivory Coast (Albiez et al. 1987). Our assumption that about
10% of worms die annually is based on these figures. The
approximately 10% of the adult worm population, which
die each year in chronic infections, will more or less be
replenished. Schulz-Key and Soboslay (2000) found that
such stable parasite loads are maintained in communities
with longstanding immunity despite the different intensities
of transmission. Thus differing proportions of transmitted
L3 will develop into adult worms, varying between less
than 0.1% and 10% or more, whereas most L3 are
eliminated by the host. Stable O. volvulus loads in highly
endemic foci had been shown to be an important mecha-
nism for parasite density regulation by Duerr et al. (2003).
These findings support our present results that within 2–
3 years roughly 20–30% of the adult filariae are newly
acquired worms.
Conclusions
We found our three hypotheses confirmed. (a) All the 61
adult and two of the immature of the 68 newly acquired
filariae harbored many intact endobacteria, whereas after 12
and more months of doxycycline treatment, none of the
other surviving worms harbored many endobacteria. (b)
Higher percentages of dead filariae than originally reported
were calculated, when the newly acquired worms were
excluded; therefore, the real macrofilaricidal activity of
doxycycline is higher than originally reported. This
difference was significant for the group of female filariae
after sufficient doxycycline treatment for 6 weeks. (c)
Only worms identified as newly acquired presented
normal embryogenesis and mf production, and all mf
observed in the nodule tissue harbored Wolbachia 18 and
more months after sufficient doxycycline treatment. We
conclude further that newly acquired filariae have to be
considered for proper evaluation of drug efficacy in
onchocerciasis.
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